BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moodley J, Moodley D, Pillay K, Coovadia H, Saba J, van Leeuwen R, Goodwin C, Harrigan PR, Moore KH, Stone C. Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring. J Infect Dis. 1998;178:1327-1333. [PMID: 9780252 DOI: 10.1086/314431] [Cited by in Crossref: 140] [Cited by in F6Publishing: 126] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Bunders M, Bekker V, Scherpbier H, Boer K, Godfried M, Kuijpers T. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatrica 2005;94:1571-7. [DOI: 10.1080/08035250510042951] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 3.5] [Reference Citation Analysis]
2 Alqahtani S, Kaddoumi A. Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy. PLoS One 2015;10:e0139762. [PMID: 26431339 DOI: 10.1371/journal.pone.0139762] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
3 Best BM, Capparelli EV. Implications of gender and pregnancy for antiretroviral drug dosing. Curr Opin HIV AIDS. 2008;3:277-282. [PMID: 19372979 DOI: 10.1097/coh.0b013e3282f39f7e] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nolan M, Fowler MG, Mofenson LM. Antiretroviral prophylaxis of perinatal HIV-1 transmission and the potential impact of antiretroviral resistance. J Acquir Immune Defic Syndr 2002;30:216-29. [PMID: 12045685 DOI: 10.1097/00042560-200206010-00011] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
5 Marzolini C, Rudin C, Decosterd LA, Telenti A, Schreyer A, Biollaz J, Buclin T. Transplacental passage of protease inhibitors at delivery: . AIDS 2002;16:889-93. [DOI: 10.1097/00002030-200204120-00008] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 4.0] [Reference Citation Analysis]
6 Cusato J, Allegra S, Nicolò AD, Calcagno A, D'avolio A. Precision medicine for HIV: where are we? Pharmacogenomics 2018;19:145-65. [DOI: 10.2217/pgs-2017-0123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
7 Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 5, 2001. HIV Clin Trials 2001;2:227-306. [PMID: 11590532 DOI: 10.1310/RWG0-49RM-GQH4-5BB3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
8 Capparelli E, Rakhmanina N, Mirochnick M. Pharmacotherapy of perinatal HIV. Seminars in Fetal and Neonatal Medicine 2005;10:161-75. [DOI: 10.1016/j.siny.2004.10.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
9 Akanbi MO, Scarsi KK, Taiwo B, Murphy RL. Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection. Expert Opin Pharmacother 2012;13:65-79. [PMID: 22149368 DOI: 10.1517/14656566.2012.642865] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
10 Money DM. Antiviral and antiretroviral use in pregnancy. Obstet Gynecol Clin North Am 2003;30:731-49, vii. [PMID: 14719848 DOI: 10.1016/s0889-8545(03)00089-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
11 Janssen EJH, Bastiaans DET, Välitalo PAJ, van Rossum AMC, Jacqz-Aigrain E, Lyall H, Knibbe CAJ, Burger DM. Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis. Br J Clin Pharmacol 2017;83:1287-97. [PMID: 28079918 DOI: 10.1111/bcp.13227] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
12 Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, Chotpitayasunondh T, Chearskul S, Roongpisuthipong A, Chinayon P, Karon J, Mastro TD, Simonds R. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. The Lancet 1999;353:773-80. [DOI: 10.1016/s0140-6736(98)10411-7] [Cited by in Crossref: 503] [Cited by in F6Publishing: 110] [Article Influence: 21.9] [Reference Citation Analysis]
13 Lambert JS, Nogueira SA, Abreu T, Machado ES, Costa TP, Bondarovsky M, Andrade M, Halpern M, Barbosa R, Perez M. A pilot study to evaluate the safety and feasibility of the administration of AZT/3TC fixed dose combination to HIV infected pregnant women and their infants in Rio de Janeiro, Brazil. Sex Transm Infect 2003;79:448-52. [PMID: 14663118 DOI: 10.1136/sti.79.6.448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
14 Rakhmanina N, Phelps BR. Pharmacotherapy of pediatric HIV infection. Pediatr Clin North Am 2012;59:1093-115. [PMID: 23036246 DOI: 10.1016/j.pcl.2012.07.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
15 Bustinduy AL, Kolamunnage-Dona R, Mirochnick MH, Capparelli EV, Tallo V, Acosta LP, Olveda RM, Friedman JF, Hope WW. Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum. Antimicrob Agents Chemother 2020;64:e00566-20. [PMID: 32631820 DOI: 10.1128/AAC.00566-20] [Reference Citation Analysis]
16 Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet 2002;359:1178-86. [PMID: 11955535 DOI: 10.1016/S0140-6736(02)08214-4] [Cited by in Crossref: 292] [Cited by in F6Publishing: 85] [Article Influence: 14.6] [Reference Citation Analysis]
17 Ehrhardt S, Xie C, Guo N, Nelson K, Thio CL. Breastfeeding While Taking Lamivudine or Tenofovir Disoproxil Fumarate: A Review of the Evidence. Clinical Infectious Diseases 2014;60:275-8. [DOI: 10.1093/cid/ciu798] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 5.5] [Reference Citation Analysis]
18 Fraaij PL, van Kampen JJ, Burger DM, de Groot R. Pharmacokinetics of antiretroviral therapy in HIV-1-infected children. Clin Pharmacokinet 2005;44:935-56. [PMID: 16122281 DOI: 10.2165/00003088-200544090-00004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
19 Cerveny L, Murthi P, Staud F. HIV in pregnancy: Mother-to-child transmission, pharmacotherapy, and toxicity. Biochim Biophys Acta Mol Basis Dis 2021;1867:166206. [PMID: 34197912 DOI: 10.1016/j.bbadis.2021.166206] [Reference Citation Analysis]
20 Capparelli EV, Englund JA, Connor JD, Spector SA, McKinney RE, Palumbo P, Baker CJ. Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children. J Clin Pharmacol 2003;43:133-40. [PMID: 12616665 DOI: 10.1177/0091270002239821] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
21 Kala S, Watson B, Zhang JG, Papp E, Guzman Lenis M, Dennehy M, Cameron DW, Harrigan PR, Serghides L. Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens. Antiviral Res 2018;159:45-54. [PMID: 30236532 DOI: 10.1016/j.antiviral.2018.09.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Johnson MA, Moore KH, Yuen GJ, Bye A, Pakes GE. Clinical pharmacokinetics of lamivudine. Clin Pharmacokinet. 1999;36:41-66. [PMID: 9989342 DOI: 10.2165/00003088-199936010-00004] [Cited by in Crossref: 170] [Cited by in F6Publishing: 167] [Article Influence: 7.4] [Reference Citation Analysis]
23 Pacifici GM. Pharmacokinetics of antivirals in neonate. Early Human Development 2005;81:773-80. [DOI: 10.1016/j.earlhumdev.2005.06.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
24 . 5.0 Use of antiretroviral therapy in pregnancy: BHIVA guidelines for the management of HIV infection in pregnant women 2012. HIV Med 2012;13:103-12. [DOI: 10.1111/j.1468-1293.2012.1030_6.x] [Reference Citation Analysis]
25 Laughon MM, Avant D, Tripathi N, Hornik CP, Cohen-Wolkowiez M, Clark RH, Smith PB, Rodriguez W. Drug labeling and exposure in neonates. JAMA Pediatr 2014;168:130-6. [PMID: 24322269 DOI: 10.1001/jamapediatrics.2013.4208] [Cited by in Crossref: 71] [Cited by in F6Publishing: 53] [Article Influence: 8.9] [Reference Citation Analysis]
26 Sokal EM, Paganelli M, Wirth S, Socha P, Vajro P, Lacaille F, Kelly D, Mieli-vergani G. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines. Journal of Hepatology 2013;59:814-29. [DOI: 10.1016/j.jhep.2013.05.016] [Cited by in Crossref: 121] [Cited by in F6Publishing: 100] [Article Influence: 13.4] [Reference Citation Analysis]
27 Best BM, Burchett S, Li H, Stek A, Hu C, Wang J, Hawkins E, Byroads M, Watts DH, Smith E, Fletcher CV, Capparelli EV, Mirochnick M; International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) P1026s Team. Pharmacokinetics of tenofovir during pregnancy and postpartum. HIV Med 2015;16:502-11. [PMID: 25959631 DOI: 10.1111/hiv.12252] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
28 Waitt CJ, Garner P, Bonnett LJ, Khoo SH, Else LJ. Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies. J Antimicrob Chemother 2015;70:1928-41. [PMID: 25858354 DOI: 10.1093/jac/dkv080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 13] [Article Influence: 0.4] [Reference Citation Analysis]
29 Olivero OA, Ming JM, Das S, Vazquez IL, Richardson DL, Weston A, Poirier MC. Human inter-individual variability in metabolism and genotoxic response to zidovudine. Toxicol Appl Pharmacol 2008;228:158-64. [PMID: 18206198 DOI: 10.1016/j.taap.2007.12.005] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
30 Nagot N, Kankasa C, Meda N, Hofmeyr J, Nikodem C, Tumwine JK, Karamagi C, Sommerfelt H, Neveu D, Tylleskär T, Van de Perre P; PROMISE-PEP group. Lopinavir/Ritonavir versus Lamivudine peri-exposure prophylaxis to prevent HIV-1 transmission by breastfeeding: the PROMISE-PEP trial Protocol ANRS 12174. BMC Infect Dis 2012;12:246. [PMID: 23039034 DOI: 10.1186/1471-2334-12-246] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
31 Staud F, Cerveny L, Ceckova M. Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure. J Drug Target. 2012;20:736-763. [PMID: 22994411 DOI: 10.3109/1061186x.2012.716847] [Cited by in Crossref: 77] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
32 Joseph Davey DL, Pintye J, Baeten JM, Aldrovandi G, Baggaley R, Bekker LG, Celum C, Chi BH, Coates TJ, Haberer JE, Heffron R, Kinuthia J, Matthews LT, McIntyre J, Moodley D, Mofenson LM, Mugo N, Myer L, Mujugira A, Shoptaw S, Stranix-Chibanda L, John-Stewart G; PrEP in Pregnancy Working Group. Emerging evidence from a systematic review of safety of pre-exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading? J Int AIDS Soc 2020;23:e25426. [PMID: 31912985 DOI: 10.1002/jia2.25426] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
33 Watts DH. Treating HIV During Pregnancy: An Update on Safety Issues. Drug Safety 2006;29:467-90. [DOI: 10.2165/00002018-200629060-00002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
34 Walker DM, Malarkey DE, Seilkop SK, Ruecker FA, Funk KA, Wolfe MJ, Treanor CP, Foley JF, Hahn FF, Hardisty JF, Walker VE. Transplacental carcinogenicity of 3'-azido-3'-deoxythymidine in B6C3F1 mice and F344 rats. Environ Mol Mutagen 2007;48:283-98. [PMID: 17358026 DOI: 10.1002/em.20297] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
35 Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BQ, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission: A clinical study. World J Gastroenterol 2003; 9(7): 1501-1503 [PMID: 12854150 DOI: 10.3748/wjg.v9.i7.1501] [Cited by in CrossRef: 85] [Cited by in F6Publishing: 83] [Article Influence: 4.5] [Reference Citation Analysis]
36 Sripan P, Le Coeur S, Ingsrisawang L, Cressey TR, Bouazza N, Foissac F, Ngo-Giang-Huong N, Traisathit P, Srirompotong U, Ayudhaya OP, Puangsombat A, Jungpipun J, Jittayanun K, Tréluyer JM, Jourdain G, Lallemant M, Urien S. Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy. Antivir Ther 2016;21:435-40. [PMID: 26492107 DOI: 10.3851/IMP3001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Mirochnick M, Thomas T, Capparelli E, Zeh C, Holland D, Masaba R, Odhiambo P, Fowler MG, Weidle PJ, Thigpen MC. Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob Agents Chemother. 2009;53:1170-1176. [PMID: 19114673 DOI: 10.1128/aac.01117-08] [Cited by in Crossref: 74] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
38 Taylor G, Clayden P, Dhar J, Gandhi K, Gilleece Y, Harding K, Hay P, Kennedy J, Low-beer N, Lyall H, Palfreeman A, Tookey P, Welch S, Wilkins E, de Ruiter A. British HIV Association guidelines for the management of HIV infection in pregnant women 2012: BHIVA guidelines for the management of HIV infection in pregnant women 2012. HIV Med 2012;13:87-157. [DOI: 10.1111/j.1468-1293.2012.01030.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 35] [Article Influence: 7.1] [Reference Citation Analysis]
39 Taylor GP, Low-beer N. Antiretroviral Therapy in Pregnancy: A Focus on Safety. Drug Safety 2001;24:683-702. [DOI: 10.2165/00002018-200124090-00004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
40 Mirochnick M, Best BM, Clarke DF. Antiretroviral Pharmacology: Special Issues Regarding Pregnant Women and Neonates. Clinics in Perinatology 2010;37:907-27. [DOI: 10.1016/j.clp.2010.08.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
41 Carten M, Kessler H. Zidovudine, Lamivudine, and Abacavir. In: St.georgiev V, Skowron G, Ogden R, Lange JMA, editors. Reverse Transcriptase Inhibitors in HIV/AIDS Therapy. Totowa: Humana Press; 2006. pp. 33-76. [DOI: 10.1007/978-1-59745-085-0_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Yeh RF, Rezk NL, Kashuba AD, Dumond JB, Tappouni HL, Tien HC, Chen YC, Vourvahis M, Horton AL, Fiscus SA, Patterson KB. Genital tract, cord blood, and amniotic fluid exposures of seven antiretroviral drugs during and after pregnancy in human immunodeficiency virus type 1-infected women. Antimicrob Agents Chemother 2009;53:2367-74. [PMID: 19307360 DOI: 10.1128/AAC.01523-08] [Cited by in Crossref: 43] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
43 Rakhmanina NY, van den Anker JN, Soldin SJ. Safety and Pharmacokinetics of Antiretroviral Therapy During Pregnancy: . Therapeutic Drug Monitoring 2004;26:110-5. [DOI: 10.1097/00007691-200404000-00004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
44 Bryson YJ, Mirochnick M, Stek A, Mofenson LM, Connor J, Capparelli E, Watts DH, Huang S, Hughes MD, Kaiser K, Purdue L, Asfaw Y, Keller M, Smith E; PACTG 353 Team. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials 2008;9:115-25. [PMID: 18474496 DOI: 10.1310/hct0902-115] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
45 Tomasiewicz K, Modrzewska R, Krawczuk G, Lyczak A. Lamivudine therapy for chronic hepatitis B virus infection and pregnancy: a case report. Int J Infect Dis. 2001;5:115-116. [PMID: 11468109 DOI: 10.1016/S1201-9712(01)90038-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
46 Enioutina EY, Constance JE, Stockmann C, Linakis MW, Yu T, Rower JE, Balch AH, Sherwin CM. Pharmacokinetic considerations in the use of antivirals in neonates. Expert Opin Drug Metab Toxicol 2015;11:1861-78. [PMID: 26535960 DOI: 10.1517/17425255.2015.1108963] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
47 Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet. 2002;359:1488-1489. [PMID: 11988251 DOI: 10.1016/s0140-6736(02)08425-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
48 Mahadevan U. Gastrointestinal medications in pregnancy. Best Pract Res Clin Gastroenterol. 2007;21:849-877. [PMID: 17889812 DOI: 10.1016/j.bpg.2007.06.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
49 Gerschenson M, Nguyen V, Ewings EL, Ceresa A, Shaw JA, St. Claire MC, Nagashima K, Harbaugh SW, Harbaugh JW, Olivero OA, Divi RL, Albert PS, Poirier MC. Mitochondrial Toxicity in Fetal Erythrocebus patas Monkeys Exposed Transplacentally to Zidovudine Plus Lamivudine. AIDS Research and Human Retroviruses 2004;20:91-100. [DOI: 10.1089/088922204322749530] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
50 Strauch S, Jantratid E, Dressman JB, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM. Biowaiver monographs for immediate release solid oral dosage forms: lamivudine. J Pharm Sci 2011;100:2054-63. [PMID: 21491435 DOI: 10.1002/jps.22449] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
51 Gulati A, Gerk PM. Role of placental ATP-binding cassette (ABC) transporters in antiretroviral therapy during pregnancy. J Pharm Sci 2009;98:2317-35. [PMID: 19067393 DOI: 10.1002/jps.21623] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
52 Marlink R, Kao H, Hsieh E. Clinical Care Issues for Women Living with HIV and AIDS in the United States. AIDS Research and Human Retroviruses 2001;17:1-33. [DOI: 10.1089/088922201750056753] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
53 Moodley D, Pillay K, Naidoo K, Moodley J, Johnson MA, Moore KHP, Mudd PN, Pakes GE. Pharmacokinetics of Zidovudine and Lamivudine in Neonates following Coadministration of Oral Doses Every 12 Hours. The Journal of Clinical Pharmacology 2001;41:732-41. [DOI: 10.1177/00912700122010636] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
54 Li D, Xu DZ, Choi BC, Men K, Zhang JX, Lei XY, Yan YP. Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy. J Med Virol. 2005;76:203-207. [PMID: 15834875 DOI: 10.1002/jmv.20353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
55 Kumar M, Singh T, Sinha S. Chronic hepatitis B virus infection and pregnancy. J Clin Exp Hepatol. 2012;2:366-381. [PMID: 25755458 DOI: 10.1016/j.jceh.2012.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
56 de Ruiter A, Taylor GP, Clayden P, Dhar J, Gandhi K, Gilleece Y, Harding K, Hay P, Kennedy J, Low-Beer N, Lyall H, Palfreeman A, O'Shea S, Tookey P, Tosswill J, Welch S, Wilkins E; British HIV Association. British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV Med 2014;15 Suppl 4:1-77. [PMID: 25604045 DOI: 10.1111/hiv.12185] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
57 Nunen AB, Man RA, Heijtink RA, Niesters HG, Schalm SW. Letters to the Editor. Journal of Hepatology 2000;32:1040-1. [DOI: 10.1016/s0168-8278(00)80112-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
58 Rakhmanina NY, Van Den Anker JN, Soldin SJ. Review : Therapeutic Drug Monitoring of Antiretroviral Therapy. AIDS Patient Care and STDs 2004;18:7-14. [DOI: 10.1089/108729104322740866] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
59 Chappuy H, Tréluyer JM, Jullien V, Dimet J, Rey E, Fouché M, Firtion G, Pons G, Mandelbrot L. Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother 2004;48:4332-6. [PMID: 15504861 DOI: 10.1128/AAC.48.11.4332-4336.2004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
60 Mahadevan U, Kane S. American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy. Gastroenterology. 2006;131:283-311. [PMID: 16831611 DOI: 10.1053/j.gastro.2006.04.049] [Cited by in Crossref: 93] [Cited by in F6Publishing: 65] [Article Influence: 5.8] [Reference Citation Analysis]
61 Liu MH, Sheng YJ, Liu JY, Hu HD, Zhang QF, Ren H. Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis. Ann Saudi Med 2013;33:169-76. [PMID: 23563007 DOI: 10.5144/0256-4947.2013.169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
62 Colbers AP, Hawkins DA, Gingelmaier A, Kabeya K, Rockstroh JK, Wyen C, Weizsäcker K, Sadiq ST, Ivanovic J, Giaquinto C. The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women. AIDS. 2013;27:739-748. [PMID: 23169329 DOI: 10.1097/qad.0b013e32835c208b] [Cited by in Crossref: 51] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
63 Mirochnick M. Antiretroviral Pharmacology in Pregnant Women and Their Newborns. Annals of the New York Academy of Sciences 2000;918:287-97. [DOI: 10.1111/j.1749-6632.2000.tb05498.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
64 Roustit M, Jlaiel M, Leclercq P, Stanke-Labesque F. Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women. Br J Clin Pharmacol 2008;66:179-95. [PMID: 18537960 DOI: 10.1111/j.1365-2125.2008.03220.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
65 King JR, Kimberlin DW, Aldrovandi GM, Acosta EP. Antiretroviral pharmacokinetics in the paediatric population: a review. Clin Pharmacokinet 2002;41:1115-33. [PMID: 12405863 DOI: 10.2165/00003088-200241140-00001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
66 Kuhn L, Meddows-Taylor S, Gray G, Trabattoni D, Clerici M, Shearer GM, Tiemessen C. Reduced HIV-stimulated T-helper cell reactivity in cord blood with short-course antiretroviral treatment for prevention of maternal-infant transmission. Clin Exp Immunol 2001;123:443-50. [PMID: 11298132 DOI: 10.1046/j.1365-2249.2001.01460.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
67 Fauchet F, Treluyer JM, Valade E, Benaboud S, Pannier E, Firtion G, Foissac F, Bouazza N, Urien S, Hirt D. Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour? Br J Clin Pharmacol 2014;78:1387-96. [PMID: 25040510 DOI: 10.1111/bcp.12459] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
68 Carter MM, Torres SM, Cook DL Jr, McCash CL, Yu M, Walker VE, Walker DM. Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells. Environ Mol Mutagen 2007;48:239-47. [PMID: 17358029 DOI: 10.1002/em.20282] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
69 Benaboud S, Tréluyer JM, Urien S, Blanche S, Bouazza N, Chappuy H, Rey E, Pannier E, Firtion G, Launay O, Hirt D. Pregnancy-related effects on lamivudine pharmacokinetics in a population study with 228 women. Antimicrob Agents Chemother 2012;56:776-82. [PMID: 22106227 DOI: 10.1128/AAC.00370-11] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
70 Bhadrakom C, Simonds RJ, Mei JV, Asavapiriyanont S, Sangtaweesin V, Vanprapar N, Moore KHP, Young NL, Hannon WH, Mastro TD, Shaffer N. Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood: . AIDS 2000;14:509-16. [DOI: 10.1097/00002030-200003310-00006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
71 Calamandrei G, Venerosi A, Valanzano A, Alleva E. Effects of prenatal AZT+3TC treatment on open field behavior and responsiveness to scopolamine in adult mice. Pharmacology Biochemistry and Behavior 2000;67:511-7. [DOI: 10.1016/s0091-3057(00)00386-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
72 Mandelbrot L, Peytavin G, Firtion G, Farinotti R. Maternal-fetal transfer and amniotic fluid accumulation of lamivudine in human immunodeficiency virus–infected pregnant women. American Journal of Obstetrics and Gynecology 2001;184:153-8. [DOI: 10.1067/mob.2001.108344] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
73 Mulligan N, Best BM, Wang J, Capparelli EV, Stek A, Barr E, Buschur SL, Acosta EP, Smith E, Chakhtoura N, Burchett S, Mirochnick M; IMPAACT P1026s Protocol Team. Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. AIDS 2018;32:729-37. [PMID: 29369162 DOI: 10.1097/QAD.0000000000001755] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 12.3] [Reference Citation Analysis]
74 Gilleece DY, Tariq DS, Bamford DA, Bhagani DS, Byrne DL, Clarke DE, Clayden MP, Lyall DH, Metcalfe DR, Palfreeman DA, Rubinstein DL, Sonecha MS, Thorley DL, Tookey DP, Tosswill MJ, Utting MD, Welch DS, Wright MA. British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018. HIV Med 2019;20 Suppl 3:s2-s85. [PMID: 30869192 DOI: 10.1111/hiv.12720] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
75 Jarvis B, Faulds D. Lamivudine. A review of its therapeutic potential in chronic hepatitis B. Drugs. 1999;58:101-141. [PMID: 10439933 DOI: 10.2165/00003495-199958010-00015] [Cited by in Crossref: 96] [Cited by in F6Publishing: 78] [Article Influence: 4.2] [Reference Citation Analysis]
76 Shapiro RL, Thior I, Gilbert PB, Lockman S, Wester C, Smeaton LM, Stevens L, Heymann SJ, Ndung'u T, Gaseitsiwe S, Novitsky V, Makhema J, Lagakos S, Essex M. Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana. AIDS 2006;20:1281-8. [DOI: 10.1097/01.aids.0000232236.26630.35] [Cited by in Crossref: 60] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
77 Slogrove AL, Clayden P, Abrams EJ. Toward a universal antiretroviral regimen: special considerations of pregnancy and breast feeding. Curr Opin HIV AIDS 2017;12:359-68. [PMID: 28426519 DOI: 10.1097/COH.0000000000000386] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
78 Tran TT, Keeffe EB. Management of the pregnant hepatitis B patient. Curr hepatitis rep 2008;7:12-7. [DOI: 10.1007/s11901-008-0016-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
79 Colebunders R, Hodossy B, Burger D, Daems T, Roelens K, Coppens M, Van Bulck B, Jacquemyn Y, Van Wijngaerden E, Fransen K. The effect of highly active antiretroviral treatment on viral load and antiretroviral drug levels in breast milk. AIDS 2005;19:1912-5. [PMID: 16227801 DOI: 10.1097/01.aids.0000188428.33280.41] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
80 Okereke CS. Management of HIV-infected pregnant patients in malaria-endemic areas: therapeutic and safety considerations in concomitant use of antiretroviral and antimalarial agents. Clin Ther 1999;21:1456-96; discussion 1427-8. [PMID: 10509844 DOI: 10.1016/s0149-2918(00)80004-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
81 Nurutdinova D, Overton ET. A review of nucleoside reverse transcriptase inhibitor use to prevent perinatal transmission of HIV. Expert Opin Drug Saf 2009;8:683-94. [PMID: 19715450 DOI: 10.1517/14740330903241584] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
82 Van Rompay KK, Matthews TB, Higgins J, Canfield DR, Tarara RP, Wainberg MA, Schinazi RF, Pedersen NC, North TW. Virulence and reduced fitness of simian immunodeficiency virus with the M184V mutation in reverse transcriptase. J Virol 2002;76:6083-92. [PMID: 12021341 DOI: 10.1128/jvi.76.12.6083-6092.2002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
83 Ohman I, Beck O, Vitols S, Tomson T. Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy. Epilepsia 2008;49:1075-80. [PMID: 18076642 DOI: 10.1111/j.1528-1167.2007.01471.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
84 Buckoreelall K, Cressey TR, King JR. Pharmacokinetic optimization of antiretroviral therapy in pregnancy. Clin Pharmacokinet 2012;51:639-59. [PMID: 23018528 DOI: 10.1007/s40262-012-0002-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
85 Hodel EM, Marzolini C, Waitt C, Rakhmanina N. Pharmacokinetics, Placental and Breast Milk Transfer of Antiretroviral Drugs in Pregnant and Lactating Women Living with HIV. Curr Pharm Des 2019;25:556-76. [PMID: 30894103 DOI: 10.2174/1381612825666190320162507] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
86 Loreno M, Bo P, Senzolo M, Cillo U, Naoumov N, Burra P. Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft. Transpl Int. 2005;17:730-734. [PMID: 15717218 DOI: 10.1007/s00147-004-0785-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
87 Stek AM, Best BM, Luo W, Capparelli E, Burchett S, Hu C, Li H, Read JS, Jennings A, Barr E, Smith E, Rossi SS, Mirochnick M. Effect of pregnancy on emtricitabine pharmacokinetics. HIV Med 2012;13:226-35. [PMID: 22129166 DOI: 10.1111/j.1468-1293.2011.00965.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
88 Neumanova Z, Cerveny L, Ceckova M, Staud F. Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine. Biopharm Drug Dispos 2016;37:28-38. [PMID: 26390406 DOI: 10.1002/bdd.1993] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
89 McCormack SA, Best BM. Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals. Clin Pharmacokinet 2014;53:989-1004. [PMID: 25223699 DOI: 10.1007/s40262-014-0185-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
90 Venerosi A, Calamandrei G, Alleva E. Animal models of anti-HIV drugs exposure during pregnancy. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2002;26:747-61. [DOI: 10.1016/s0278-5846(01)00325-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
91 Giuliano M, Guidotti G, Andreotti M, Pirillo MF, Villani P, Liotta G, Marazzi MC, Mancini MG, Cusato M, Germano P, Loureiro S, Ceffa S, Regazzi M, Vella S, Palombi L. Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program. J Acquir Immune Defic Syndr 2007;44:286-91. [PMID: 17146372 DOI: 10.1097/QAI.0b013e31802c5441] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
92 Achenbach CJ, Scarsi KK, Murphy RL. Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV. Adv Ther 2010;27:1-16. [PMID: 20204580 DOI: 10.1007/s12325-010-0006-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
93 Kosel BW, Beckerman KP, Hayashi S, Homma M, Aweeka FT. Pharmacokinetics of nelfinavir and indinavir in HIV-1-infected pregnant women: . AIDS 2003;17:1195-9. [DOI: 10.1097/00002030-200305230-00011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
94 Venhoff N, Walker UA. Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opin Drug Saf 2006;5:373-81. [PMID: 16610967 DOI: 10.1517/14740338.5.3.373] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
95 van Zonneveld M, van Nunen AB, Niesters HG, de Man RA, Schalm SW, Janssen HL. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepat. 2003;10:294-297. [PMID: 12823596 DOI: 10.1046/j.1365-2893.2003.00440.x] [Cited by in Crossref: 199] [Cited by in F6Publishing: 172] [Article Influence: 10.5] [Reference Citation Analysis]
96 Loreno M, Bo P, Senzolo M, Cillo U, Naoumov N, Burra P. Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft. Transplant Int 2004;17:730-4. [DOI: 10.1111/j.1432-2277.2004.tb00502.x] [Reference Citation Analysis]
97 Forestier F, de Renty P, Peytavin G, Dohin E, Farinotti R, Mandelbrot L. Maternal-fetal transfer of saquinavir studied in the ex vivo placental perfusion model. American Journal of Obstetrics and Gynecology 2001;185:178-81. [DOI: 10.1067/mob.2001.113319] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.1] [Reference Citation Analysis]
98 Hoody DW, Fletcher CV. Pharmacology considerations for antiretroviral therapy in human immunodeficiency virus (HIV)-infected children. Seminars in Pediatric Infectious Diseases 2003;14:286-94. [DOI: 10.1053/j.spid.2003.09.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
99 Feghali MN, Mattison DR. Clinical therapeutics in pregnancy. J Biomed Biotechnol 2011;2011:783528. [PMID: 21785566 DOI: 10.1155/2011/783528] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
100 Venerosi A, Valanzano A, Alleva E, Calamandrei G. Prenatal exposure to anti-HIV drugs: Neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice. Teratology 2001;63:26-37. [DOI: 10.1002/1096-9926(200101)63:1<26::aid-tera1005>3.0.co;2-g] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
101 Lewis SR, White CA, Bartlett MG. Simultaneous determination of abacavir and zidovudine from rat tissues using HPLC with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci 2007;850:45-52. [PMID: 17118723 DOI: 10.1016/j.jchromb.2006.10.070] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
102 Su GG, Pan KH, Zhao NF, Fang SH, Yang DH, Zhou Y. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10(6): 910-912 [PMID: 15040044 DOI: 10.3748/wjg.v10.i6.910] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
103 Gaillard P, Fowler M, Dabis F, Coovadia H, van der Horst C, van Rompay K, Ruff A, Taha T, Thomas T, de Vincenzi I, Newell M. Use of Antiretroviral Drugs to Prevent HIV-1 Transmission Through Breast-feeding: From Animal Studies to Randomized Clinical Trials: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2004;35:178-87. [DOI: 10.1097/00126334-200402010-00013] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 3.8] [Reference Citation Analysis]
104 Calamandrei G, Venerosi A, Branchi I, Valanzano A, Alleva E. Prenatal exposure to anti-HIV drugs. long-term neurobehavioral effects of lamivudine (3TC) in CD-1 mice. Neurotoxicol Teratol. 2000;22:369-379. [PMID: 10840180 DOI: 10.1016/s0892-0362(00)00063-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
105 Mirochnick M, Capparelli E. Pharmacokinetics of Antiretrovirals in Pregnant Women: . Clinical Pharmacokinetics 2004;43:1071-87. [DOI: 10.2165/00003088-200443150-00002] [Cited by in Crossref: 111] [Cited by in F6Publishing: 103] [Article Influence: 6.2] [Reference Citation Analysis]
106 Back D, Gatti G, Fletcher C, Garaffo R, Haubrich R, Hoetelmans R, Kurowski M, Luber A, Merry C, Perno C. Therapeutic drug monitoring in HIV infection: current status and future directions: . AIDS 2002;16:S5-S37. [DOI: 10.1097/00002030-200203001-00002] [Cited by in Crossref: 117] [Cited by in F6Publishing: 115] [Article Influence: 5.9] [Reference Citation Analysis]
107 Abduljalil K, Pansari A, Ning J, Jamei M. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach. Clin Pharmacokinet. [DOI: 10.1007/s40262-021-01103-0] [Reference Citation Analysis]
108 Visvanathan K, Dusheiko G, Giles M, Wong ML, Phung N, Walker S, Le S, Lim SG, Gane E, Ngu M. Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut. 2016;65:340-350. [PMID: 26475631 DOI: 10.1136/gutjnl-2015-310317] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
109 Olagunju A, Owen A, Cressey TR. Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding. Pharmacogenomics 2012;13:1501-22. [PMID: 23057550 DOI: 10.2217/pgs.12.138] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
110 Rodman JH. Design of antiretroviral clinical trials for HIV-1 infected pregnant women and their newborn infants. Semin Perinatol 2001;25:170-6. [PMID: 11453614 DOI: 10.1053/sper.2001.24904] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
111 Van Rompay KK, Hamilton M, Kearney B, Bischofberger N. Pharmacokinetics of tenofovir in breast milk of lactating rhesus macaques. Antimicrob Agents Chemother 2005;49:2093-4. [PMID: 15855535 DOI: 10.1128/AAC.49.5.2093-2094.2005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
112 Isoherranen N, Thummel KE. Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metab Dispos 2013;41:256-62. [PMID: 23328895 DOI: 10.1124/dmd.112.050245] [Cited by in Crossref: 113] [Cited by in F6Publishing: 104] [Article Influence: 12.6] [Reference Citation Analysis]
113 Moore KH, Shaw S, Laurent AL, Lloyd P, Duncan B, Morris DM, O'Mara MJ, Pakes GE. Lamivudine/zidovudine as a combined formulation tablet: bioequivalence compared with lamivudine and zidovudine administered concurrently and the effect of food on absorption. J Clin Pharmacol 1999;39:593-605. [PMID: 10354963 DOI: 10.1177/00912709922008209] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
114 Kijak GH, Avila MM, Salomón H. Mother-to-child transmission of drug-resistant HIV. Drug Resistance Updates 2001;4:29-37. [DOI: 10.1054/drup.2001.0182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
115 Melnick SM, Weedon J, Dow-Edwards DL. Perinatal AZT exposure alters the acoustic and tactile startle response to 8-OH-DPAT and apomorphine in adult rats. Neurotoxicol Teratol 2005;27:599-608. [PMID: 15994058 DOI: 10.1016/j.ntt.2005.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
116 Mennecier A, Kankasa C, Fao P, Moles JP, Eymard-Duvernay S, Mwiya M, Kania D, Chunda-Liyoka C, Sakana L, Rutagwera D, Tassembedo S, Wilfred-Tonga MM, Mosqueira B, Tylleskär T, Nagot N, Van de Perre P; ANRS 12397 Study group. Design and challenges of a large HIV prevention clinical study on mother-to-child transmission: ANRS 12397 PROMISE-EPI study in Zambia and Burkina Faso. Contemp Clin Trials 2021;105:106402. [PMID: 33872801 DOI: 10.1016/j.cct.2021.106402] [Reference Citation Analysis]
117 Kumar PN, Patel P. Lamivudine for the treatment of HIV. Expert Opinion on Drug Metabolism & Toxicology 2009;6:105-14. [DOI: 10.1517/17425250903490418] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
118 Kelly E, Peters MG. Management of HBV in Pregnancy. Curr Hepatology Rep 2015;14:145-52. [DOI: 10.1007/s11901-015-0266-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
119 Olivero OA, Fernandez JJ, Antiochos BB, Wagner JL, St. Claire ME, Poirier MC. Transplacental Genotoxicity of Combined Antiretroviral Nucleoside Analogue Therapy in Erythrocebus patas Monkeys: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2002;29:323-9. [DOI: 10.1097/00126334-200204010-00001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.1] [Reference Citation Analysis]
120 Sookoian S. Effect of pregnancy on pre-existing liver disease: Chronic viral hepatitis. Annals of Hepatology 2006;5:190-7. [DOI: 10.1016/s1665-2681(19)32009-5] [Cited by in Crossref: 15] [Article Influence: 0.9] [Reference Citation Analysis]
121 Mirochnick M, Rodman JH, Robbins BL, Fridland A, Gandía J, Hitti J, Bardeguez A, Rathore MH, Gonzalez Garcia A, Cababasay M, Samson P, Mofenson L, Bryson YJ, Dorenbaum A. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study. HIV Med 2007;8:451-6. [PMID: 17760737 DOI: 10.1111/j.1468-1293.2007.00495.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
122 Michalik DE, Jackson-Alvarez JT, Flores R, Tolentino-Baldridge C, Batra JS. Low Third-Trimester Serum Levels of Lamivudine/Zidovudine and Lopinavir/Ritonavir in an HIV-Infected Pregnant Woman with Gastric Bypass. J Int Assoc Provid AIDS Care 2015;14:116-9. [PMID: 25361558 DOI: 10.1177/2325957414555231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
123 Best BM, Mirochnick M, Capparelli EV, Stek A, Burchett SK, Holland DT, Read JS, Smith E, Hu C, Spector SA, Connor JD; PACTG P1026s Study Team. Impact of pregnancy on abacavir pharmacokinetics. AIDS 2006;20:553-60. [PMID: 16470119 DOI: 10.1097/01.aids.0000210609.52836.d1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
124 DiFrancesco R, Maduke G, Patel R, Taylor CR, Morse GD. Antiretroviral bioanalysis methods of tissues and body biofluids. Bioanalysis 2013;5:351-68. [PMID: 23394701 DOI: 10.4155/bio.12.319] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
125 Divi RL, Doerge DR, Twaddle NC, Shockley ME, St Claire MC, Harbaugh JW, Harbaugh SW, Poirier MC. Metabolism and pharmacokinetics of the combination Zidovudine plus Lamivudine in the adult Erythrocebus patas monkey determined by liquid chromatography-tandem mass spectrometric analysis. Toxicol Appl Pharmacol 2008;226:206-11. [PMID: 17949768 DOI: 10.1016/j.taap.2007.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
126 Coelho AV, Tricarico PM, Celsi F, Crovella S. Antiretroviral Treatment in HIV-1-Positive Mothers: Neurological Implications in Virus-Free Children. Int J Mol Sci 2017;18:E423. [PMID: 28212307 DOI: 10.3390/ijms18020423] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
127 Tuntland T, Odinecs A, Pereira CM, Nosbisch C, Unadkat JD. In vitro models to predict the in vivo mechanism, rate, and extent of placental transfer of dideoxynucleoside drugs against human immunodeficiency virus. Am J Obstet Gynecol 1999;180:198-206. [PMID: 9914604 DOI: 10.1016/s0002-9378(99)70175-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
128 Levy MT. Preventing Perinatal Transmission of HBV: An Australian Perspective. Curr Hepatitis Rep 2012;11:206-12. [DOI: 10.1007/s11901-012-0144-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
129 Taylor GP, Lyall EG, Mercey D, Smith R, Chester T, Newell ML, Tudor-Williams G. British HIV Association guidelines for prescribing antiretroviral therapy in pregnancy (1998). Sex Transm Infect 1999;75:90-7. [PMID: 10448360 DOI: 10.1136/sti.75.2.90] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]